European regulators have started a review into the safety of Gilead Sciences’ leukemia drug Zydelig over concerns about serious adverse events, including deaths.
Forex – financial instrument.Forex news
European regulators have started a review into the safety of Gilead Sciences’ leukemia drug Zydelig over concerns about serious adverse events, including deaths.